Rutanen J - Search Results

1

PDGF-C and -D and their receptors PDGFR-alpha and PDGFR-beta in atherosclerotic human arteries.

Karvinen H, Rutanen J, Leppänen O, Lach R, Levonen AL, Eriksson U, Ylä-Herttuala S. Karvinen H, et al. Among authors: rutanen j. Eur J Clin Invest. 2009 Apr;39(4):320-7. doi: 10.1111/j.1365-2362.2009.02095.x. Eur J Clin Invest. 2009. PMID: 19292888

2

Clinical applications of vascular gene therapy.

Rutanen J, Rissanen TT, Kivelä A, Vajanto I, Ylä-Herttuala S. Rutanen J, et al. Curr Cardiol Rep. 2001 Jan;3(1):29-36. doi: 10.1007/s11886-001-0007-z. Curr Cardiol Rep. 2001. PMID: 11139796 Review.

3

Expression of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 (KDR/Flk-1) in ischemic skeletal muscle and its regeneration.

Rissanen TT, Vajanto I, Hiltunen MO, Rutanen J, Kettunen MI, Niemi M, Leppänen P, Turunen MP, Markkanen JE, Arve K, Alhava E, Kauppinen RA, Ylä-Herttuala S. Rissanen TT, et al. Among authors: rutanen j. Am J Pathol. 2002 Apr;160(4):1393-403. doi: 10.1016/S0002-9440(10)62566-7. Am J Pathol. 2002. PMID: 11943724 Free PMC article.

4

DNA hypomethylation and methyltransferase expression in atherosclerotic lesions.

Hiltunen MO, Turunen MP, Häkkinen TP, Rutanen J, Hedman M, Mäkinen K, Turunen AM, Aalto-Setälä K, Ylä-Herttuala S. Hiltunen MO, et al. Among authors: rutanen j. Vasc Med. 2002 Feb;7(1):5-11. doi: 10.1191/1358863x02vm418oa. Vasc Med. 2002. PMID: 12083735

5

Gene therapy for restenosis: current status.

Rutanen J, Markkanen J, Ylä-Herttuala S. Rutanen J, et al. Drugs. 2002;62(11):1575-85. doi: 10.2165/00003495-200262110-00001. Drugs. 2002. PMID: 12109921 Review.

6

Evaluation of angiogenesis and side effects in ischemic rabbit hindlimbs after intramuscular injection of adenoviral vectors encoding VEGF and LacZ.

Vajanto I, Rissanen TT, Rutanen J, Hiltunen MO, Tuomisto TT, Arve K, Närvänen O, Manninen H, Räsänen H, Hippeläinen M, Alhava E, Ylä-Herttuala S. Vajanto I, et al. Among authors: rutanen j. J Gene Med. 2002 Jul-Aug;4(4):371-80. doi: 10.1002/jgm.287. J Gene Med. 2002. PMID: 12124979

7

Peptide-retargeted adenovirus encoding a tissue inhibitor of metalloproteinase-1 decreases restenosis after intravascular gene transfer.

Turunen MP, Puhakka HL, Koponen JK, Hiltunen MO, Rutanen J, Leppänen O, Turunen AM, Närvänen A, Newby AC, Baker AH, Ylä-Herttuala S. Turunen MP, et al. Among authors: rutanen j. Mol Ther. 2002 Sep;6(3):306-12. doi: 10.1006/mthe.2002.0668. Mol Ther. 2002. PMID: 12231165 Free article.

8

Adenovirus-mediated extracellular superoxide dismutase gene therapy reduces neointima formation in balloon-denuded rabbit aorta.

Laukkanen MO, Kivelä A, Rissanen T, Rutanen J, Karkkainen MK, Leppanen O, Bräsen JH, Yla-Herttuala S. Laukkanen MO, et al. Among authors: rutanen j. Circulation. 2002 Oct 8;106(15):1999-2003. doi: 10.1161/01.cir.0000031331.05368.9d. Circulation. 2002. PMID: 12370226

9

Post-intervention vessel remodeling.

Rutanen J, Puhakka H, Ylä-Herttuala S. Rutanen J, et al. Gene Ther. 2002 Nov;9(22):1487-91. doi: 10.1038/sj.gt.3301866. Gene Ther. 2002. PMID: 12407420 Review.

10

Fibroblast growth factor 4 induces vascular permeability, angiogenesis and arteriogenesis in a rabbit hindlimb ischemia model.

Rissanen TT, Markkanen JE, Arve K, Rutanen J, Kettunen MI, Vajanto I, Jauhiainen S, Cashion L, Gruchala M, Närvänen O, Taipale P, Kauppinen RA, Rubanyi GM, Ylä-Herttuala S. Rissanen TT, et al. Among authors: rutanen j. FASEB J. 2003 Jan;17(1):100-2. doi: 10.1096/fj.02-0377fje. Epub 2002 Nov 15. FASEB J. 2003. PMID: 12475908

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

55 results

Search Page

Filters